Clinical trial
Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
NCT03462459 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 21, 2018
- Completion date
- July 6, 2023
- Enrollment
- 79 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
c. diff colitis, c.difficile colitis, c.difficile diarrhea, cdi, clostridium difficile infection, recurrent clostridium difficile infection